Indications and uses
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Grocery Outlet Guaifenesin Extended Release Tablets USP 600 mg
- Manufacturer
- Grocery Outlet, Inc. | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2026-03-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 01:52:28
Label at a glance#
ProductMucus Relief
Active ingredientGUAIFENESIN
Label structure10 sections
Dosage and administration
do not crush, chew, or break extended-release tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: 1 or 2 extended-release tablets every 12 hours. Do not exceed 4 extended-release tablets in 24 hours. children under 12 years of age: do not use
Storage and handling
store at 20-25°C (68-77°F)
Contacts and useful links#
Label contents#
Full prescribing information#
Drug Facts
-
Active ingredient (in each extended-release tablet)
Guaifenesin, USP 600 mg
Purpose
Expectorant
Uses
- helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Warnings
-
Do not use
- for children under 12 years of age
Ask a doctor before use if you have
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- cough accompanied by too much phlegm (mucus)
Stop use and ask a doctor if
- cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
If pregnant or breast-feeding,
ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Directions
- do not crush, chew, or break extended-release tablet
- take with a full glass of water
- this product can be administered without regard for the timing of meals
- adults and children 12 years of age and over: 1 or 2 extended-release tablets every 12 hours. Do not exceed 4 extended-release tablets in 24 hours.
- children under 12 years of age: do not use
Other information
- store at 20-25°C (68-77°F)
Inactive ingredients
colloidal silicon dioxide, copovidone, FD&C blue no. 1 aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone (K-30), sodium starch glycolate, stearic acid.
Questions or comments?
Call 1-877-290-4008
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85828-723-02 | Mucus Relief | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 2 | |
| 85828-723-02 | Mucus Relief | 20 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 20 | 2 |
Products#
Every source-derived product name is available through these pages.
- Mucus Relief
- Guaifenesin
- MICROCRYSTALLINE CELLULOSE 102
- POVIDONE K30
- SODIUM STARCH GLYCOLATE TYPE A
- SILICON DIOXIDE
- HYPROMELLOSE, UNSPECIFIED
- MALTODEXTRIN
- MAGNESIUM STEARATE
- STEARIC ACID
- COPOVIDONE K25-31
- FD&C BLUE NO. 1 ALUMINUM LAKE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 85828-723 | 85828-723-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217780-001 | GUAIFENESIN | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | ||
| A217780-002 | GUAIFENESIN | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A217780-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A217780-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2023-08-21 | a72a2bbeb626… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mucus Relief | GUAIFENESIN | Grocery Outlet, Inc. | 4466623c-6387-e725-e063-6394a90ad95e | 2026-03-14 | Warnings | 85828-723-02 85828-723 85828072302 4cf63f34-143f-6575-e063-6294a90a0f80 4466623c-6387-e725-e063-6394a90ad95e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.